Abrogation of shedding of immunosuppressive neuroblastoma gangliosides

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4602-4605

  Li, Ruixiang ^b   Ladisch, Stephan ^a  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE DERIVATIVE; GANGLIOSIDE;

ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NEUROBLASTOMA; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; TUMOR GROWTH;

CELL DIVISION; CHOLINE; GANGLIOSIDES; GLUCOSYLTRANSFERASES; HUMANS; MORPHOLINES; NEOPLASM PROTEINS; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0029795428     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ladisch, S., Gillard, B , Wong, C., and Ulsh, L. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res., 43 3808-3813, 1983.
2. Shaposhnikova, G. I., Prokazova, N. V , Buznikov, G. A., Zvezdina, N. D., Teplitz, N. A., and Bergelson, L. D. Shedding of gangliosides from tumor cells depends on cell density. Eur J. Biochem., 140: 567-570, 1984.
3. D3 shedding by human malignant melanoma cells. Int J Cancer, 44: 155-160, 1989.
4. Li, R., and Ladisch, S Shedding of human neuroblastoma gangliosides Biochim Biophys Acta, 1083: 57-64, 1991.
5. Li, R , Gage, D., and Ladisch, S. Biosynthesis and shedding of lymphoma gangliosides. Biochim. Biophys Acta, 1170: 283-290, 1993.
6. Skipski, V P , Katopodis, N., Prendergast, J. S , and Stock, C C Gangliosides in blood serum of normal rats and morris Hepatoma 5123tc-bearing rats. Biochem. Biophys. Res Commun , 67 1122-1127, 1975
7. Kloppel, T. M , Keenan, T. W , Freeman, M J., and Morre, D. J. Glycolipid-bound sialic acid in serum increased levels in mice and humans bearing mammary carcinomas. Proc. Natl. Acad. Sci. USA, 74: 3011-3013, 1977.
8. Black, P. H. Shedding from the cell surface of normal and cancer cells. Adv. Cancer Res , 32. 75-199, 1980.
9. Ladisch, S., and Wu, Z-L Detection of a tumor-associated ganglioside in plasma of patients with neuroblastoma. Lancet, i: 136-138, 1985.
10. D2 ganglioside by human neuroblastoma. Int. J. Cancer, 39: 73-76, 1987
11. Ladisch, S , Kitada, S., and Hays, E Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest , 79. 1879-1882, 1987.
12. Portoukalian, J. Immunoregulatory activity of gangliosides shed by melanoma tumors. In: H. S. Oettgen (ed.), Gangliosides and Cancer, pp. 207-216, Weinheim, Germany: VCH Verlag, 1989
13. Bergelson, L. D , Dyatlovitskaya, E. V , Klyuchareva, T. E., Kryukova, E. V , Lemenovskaya, A. F , Matveeva, V. A., and Sinitsyna, E V The role of glycosphingolipids in natural immunity Gangliosides modulate the cytotoxicity of natural killer cells. Eur J. Immunol., 19: 1979-1983, 1989.
14. Valentino, L., Moss, T , Olson, E., Wang, H-J., Elashoff, R., and Ladisch, S. Shed tumor gangliosides and progression of human neuroblastoma. Blood, 75. 1564-1567, 1990.
15. Li, R., Villacreses, N , and Ladisch, S. Human tumor gangliosides inhibit murine immune responses in vivo Cancer Res , 55: 211-214, 1995.
16. Ladisch, S., Li, R , and Olson, E Ceramide structure predicts tumor ganglioside immunosuppressive activity Proc. Natl. Acad. Sci. USA. 91: 1974-1978, 1994.
17. D2. Glycoconj. J., 13: 385-389, 1996
18. Inokuchi, J-i , and Radin, N. S. Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase J. Lipid Res , 28 565-571, 1987.
19. Radin, N S , Shayman, J. A , and Inokuchi, J-i Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res., 26: 183-213, 1993.
20. Liepkalns, V. A , Icard, C , Yates, A. J , Thompson, D. K., and Hart, R. W Effects of cell density on lipids of human glioma and fetal neural cells. J Neurochem., 36: 1959-1965, 1981.
21. Schengrund, C-L., and Repman, M A. Density-dependent changes in gangliosides and sialidase activity of murine neuroblastoma cells. J. Neurochem., 39: 940-947, 1982
22. Kemp, S. F. and Stoolmiller, A C Biosynthesis of glycosphingolipids in cultured mouse neuroblastoma cells. J Biol. Chem., 251 7626-7631, 1976
23. Li, R., and Ladisch, S. Alteration of neuroblastoma ganglioside metabolism by retinoic acid. J. Neurochem., 59: 2297-2303, 1992
24. Ladisch, S , and Gillard, B. A solvent partition method for microscale ganglioside purification Anal Biochem., 146: 220-231, 1985.
25. Ledeen, R., and Yu, R. Gangliosides Structures, isolation and analysis. Methods Enzymol , 83: 139-191, 1982
26. Barbour, S , Edidin, M., Felding-Habermann, B., Taylor-Norton, J., Radin, N. S., and Fenderson, B A. Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells. J. Cell. Physiol., 150. 610-619, 1992.
27. Nagai, Y., Nakaishi, H , and Sanai, Y. Gene transfer as a novel approach to the gene-controlled mechanism of the cellular expression of glycosphingolipids. Chem. Phys. Lipids, 42. 91-103, 1986.
28. D3 and b-series gangliosides in Neuro2a cells J Biol. Chem., 269 30451-30456, 1994.
29. Zeng, G., Ariga, T., Gu, X-B , and Yu, R. K Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation Proc Natl. Acad Sci USA, 92: 8670-8674, 1995.
30. Inokuchi, J-i., Jimbo, M , Momosaki, K., Shimeno, H., Nagamatsu, A., Nagamatsu, A., and Radin, N. S Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action Cancer Res , 50: 6731-6737, 1990.
31. Inokuchi, J-i., Momosaki, K , Shimeno, H , Nagamatsu, A., and Radin, N S Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells. J. Cell. Physiol., 141. 573-583, 1989
32. Shukla, G. S., Shukla, A., Inokuchi, J-i , and Radin, N S. Rapid kidney changes resulting from glucosphingolipid depletion by treatment with a glucosyltransferase inhibitor Biochim. Biophys. Acta, 1083: 101-108, 1991
33. Hakomori, S-I. New directions in cancer therapy based on aberrant expression of glycosphingolipids, anti-adhesion and ortho-signaling therapy. Cancer Cells (Cold Spring Harbor), 3: 461-470, 1991